Philip Morris International Inc. (PM) Rises 0.56% After Earnings, Revenue Falls Short

2026-02-06 · Stocks · QuoteReporter

Post Earning Analysis

Philip Morris International Inc. (PM) Rises 0.56% After Earnings, Revenue Falls Short

Philip Morris International, Inc., founded in 1847 and headquartered in Stamford, CT, is a leading tobacco company transitioning towards a smoke-free future. It aims to diversify its portfolio beyond tobacco and nicotine products. The company operates globally, segmented into Europe, South and Southeast Asia, the Commonwealth of Independent States, the Middle East, Africa, East Asia, Australia, international duty-free markets, and the Americas.

Philip Morris International (PM) recently reported its Q4 earnings, revealing a mixed set of outcomes that have influenced its stock performance. On February 6, 2026, multiple sources reported that Philip Morris’s Q4 earnings exceeded estimates, with the company posting higher profit and revenue and forecasting continued growth. Despite these positive results, the stock experienced a retreat following the announcement. This decline could be attributed to the company’s earnings meeting, but not exceeding, market expectations, leading to a cautious response from investors.

Philip Morris’s performance is critical as it reflects not only on its financial health but also on broader market sentiments towards tobacco and consumer staples during economic fluctuations. The company’s ability to maintain profitability and revenue growth amidst challenges in the tobacco industry could reassure investors about its resilience and strategic direction. However, the immediate stock retreat indicates market sensitivity to not just meeting but significantly surpassing earnings expectations to sustain investor confidence and stock momentum.

The current price of $184.11 shows a modest daily increase of 0.56%. This price is very close to its 52-week and year-to-date high of $184.67, indicating a strong upward trend. The narrow gap between the current price and these highs, with a percentage difference of just -0.3%, suggests that the asset is testing its resistance level.

The asset has shown substantial growth from its 52-week low of $135.24 and even more from the YTD low of $112.16, with increases of 36.14% and 64.15% respectively. This robust performance is also reflected in the moving averages, with the current price exceeding the 20-day MA by 5.69%, the 50-day MA by 13.01%, and the 200-day MA by 12.4%.

The RSI at 73.03 points to the asset being potentially overbought, which could indicate a pullback or consolidation in the near term. Additionally, a MACD of 5.64 supports the strong bullish momentum but also warrants caution for potential reversal due to the high RSI. Overall, the asset is currently performing well, but investors should be wary of possible corrections following the rapid gains.

Philip Morris International (PM) reported a robust financial performance for Q4 2025, with significant improvements across key metrics. The company achieved a reported diluted EPS of $1.37, marking a complete turnaround from a loss of $(0.38) in the same quarter the previous year. Adjusted diluted EPS also rose by 9.7% to $1.70. Net revenues increased by 6.8% year-over-year to $10.362 billion, driven by growth in both smoke-free products and traditional offerings.

The total shipment volume slightly increased by 0.1% to 193.8 billion units. Notably, smoke-free products saw an 8.5% increase in shipments, highlighting a shift in consumer preferences. The heated tobacco units and oral smoke-free products also experienced growth, contributing positively to the revenue mix.

For the full year, net revenues were up by 7.3% to $40.648 billion, and operating income improved by 11.1% to $14.892 billion. The smoke-free segment notably expanded, representing 41.5% of total net revenues, underscoring its increasing importance to the company’s strategy.

Looking ahead, Philip Morris anticipates a reported diluted EPS for the next year in the range of $7.87 to $8.02, reflecting continued growth expectations. The company is focusing on high single-digit growth in smoke-free product volumes and projects a net revenue growth of 5% to 7% on an organic basis.

Earnings Trend Table

The analysis of the EPS (Earnings Per Share) trends over the observed quarters reveals a generally positive performance with most quarters exceeding analyst estimates. Notably, the company met its EPS estimate in the latest quarter reported on 2026-02-06, with both the estimate and reported EPS at 1.70, indicating stability in performance expectations and outcomes.

A closer look at the data shows a pattern of surpassing EPS estimates in six out of the eight quarters. The most significant positive surprise occurred in the quarter ending on 2024-04-23, where the reported EPS of 1.50 exceeded the estimate of 1.41 by 6.26%. Another notable overachievement was on 2024-10-22, with a surprise percentage of 4.83% as the reported EPS of 1.91 surpassed the estimate of 1.82.

Conversely, there is an instance of underperformance on 2024-02-08, where the reported EPS of 1.36 fell below the estimate by 5.98%. This indicates a potential volatility or unexpected challenges during that period.

Overall, the trend suggests a generally robust earnings performance, with occasional fluctuations that warrant careful monitoring for underlying causes and potential impacts on future performance.

Dividend Payments Table

The dividend data provided reveals a clear trend of increasing dividends over the observed period. Starting in March 2024, dividends were recorded at $1.30 and maintained this level through June 2024. Subsequent quarters show a gradual increase; dividends rose to $1.35 by September 2024 and remained steady at this rate through the second quarter of 2025.

A notable increment occurred in the latter half of 2025, where dividends increased to $1.47 by June and were maintained at this higher rate through December. This progression indicates a positive trend in dividend payouts over the two-year span, suggesting an improving financial position or a strategy to return more capital to shareholders. The consistency in the timing of these payouts, typically aligning with the end of financial quarters, also reflects a structured and predictable dividend policy, which is often appreciated by investors seeking regular income streams.

In the most recent series of rating changes, the financial firms Jefferies, Needham, and UBS have adjusted their stances on the subject entity, reflecting varying levels of confidence in its market performance.

1. Jefferies – Downgrade (2026-01-20): Jefferies downgraded its rating from “Buy” to “Hold” and set a target price of $180. This downgrade suggests a shift in perspective, possibly due to perceived limited upside potential or emerging risks that could constrain the entity’s future growth or profitability.

2. Jefferies – Resumption (2025-07-09): Earlier, Jefferies resumed coverage with a “Buy” rating, assigning a more optimistic target price of $220. This indicates a positive outlook at that time, perhaps influenced by favorable market conditions, strong financial performance, or strategic initiatives expected to drive value.

3. Needham – Initiation (2025-05-22): Needham initiated coverage with a “Buy” rating and a target price of $195. The initiation of coverage with a buy rating reflects Needham’s confidence in the entity’s potential for growth and a bullish outlook on its market position and financial health.

4. UBS – Upgrade (2025-04-25): UBS upgraded its rating from “Sell” to “Neutral” and set a target price of $170. This upgrade indicates a revised assessment, possibly due to mitigation of previously identified risks or better-than-expected company performance, suggesting a neutral stance with no significant negative drivers anticipated in the near term.

These rating changes collectively provide insights into the evolving financial analysis and market expectations surrounding the entity, highlighting the dynamic nature of equity evaluations in response to new information and market developments.

The current price of the stock is $184.11, which shows a mixed position relative to the average target prices provided by various analysts. The latest downgrade by Jefferies on January 20, 2026, adjusted their target price to $180 and changed their rating from Buy to Hold, suggesting a potential slight decrease or stabilization in the stock’s future price. This contrasts with their earlier more optimistic target of $220 on July 9, 2025. Needham, on May 22, 2025, initiated coverage with a Buy rating and a target price of $195, indicating a belief in potential growth above the current market price. Earlier, on April 25, 2025, UBS upgraded the stock from Sell to Neutral with a target price of $170, which is below the current price, reflecting a more cautious outlook at that time.

Overall, the average target price from these analysts suggests a slight upward potential, but with recent downgrades, the outlook might be more conservative. The EPS (Earnings Per Share) and dividend trends are not provided in the data, so no commentary on those aspects can be made.

Disclaimer: The information provided here is for educational and informational purposes only and should not be interpreted as financial advice, investment recommendations, or trading guidance. Markets involve risk, and past performance is not indicative of future results. You should always conduct your own research and consult with a qualified financial advisor before making any investment decisions. By acting, you accept full responsibility for your choices.